Back to Search
Start Over
α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD + ) Biosynthesis.
- Source :
-
Journal of medicinal chemistry [J Med Chem] 2018 Feb 08; Vol. 61 (3), pp. 745-759. Date of Electronic Publication: 2018 Jan 26. - Publication Year :
- 2018
-
Abstract
- NAD <superscript>+</superscript> has a central function in linking cellular metabolism to major cell-signaling and gene-regulation pathways. Defects in NAD <superscript>+</superscript> homeostasis underpin a wide range of diseases, including cancer, metabolic disorders, and aging. Although the beneficial effects of boosting NAD <superscript>+</superscript> on mitochondrial fitness, metabolism, and lifespan are well established, to date, no therapeutic enhancers of de novo NAD <superscript>+</superscript> biosynthesis have been reported. Herein we report the discovery of 3-[[[5-cyano-1,6-dihydro-6-oxo-4-(2-thienyl)-2-pyrimidinyl]thio]methyl]phenylacetic acid (TES-1025, 22), the first potent and selective inhibitor of human ACMSD (IC <subscript>50</subscript> = 0.013 μM) that increases NAD <superscript>+</superscript> levels in cellular systems. The results of physicochemical-property, ADME, and safety profiling, coupled with in vivo target-engagement studies, support the hypothesis that ACMSD inhibition increases de novo NAD <superscript>+</superscript> biosynthesis and position 22 as a first-class molecule for the evaluation of the therapeutic potential of ACMSD inhibition in treating disorders with perturbed NAD <superscript>+</superscript> supply or homeostasis.
Details
- Language :
- English
- ISSN :
- 1520-4804
- Volume :
- 61
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of medicinal chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 29345930
- Full Text :
- https://doi.org/10.1021/acs.jmedchem.7b01254